Advanced Medical Solutions Group (LON:AMS) Shares Pass Above 200-Day Moving Average – Time to Sell?

Advanced Medical Solutions Group plc (LON:AMS)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 210.91 and traded as high as GBX 212. Advanced Medical Solutions Group shares last traded at GBX 208.50, with a volume of 721,488 shares changing hands.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on AMS. Peel Hunt reiterated a “buy” rating and issued a GBX 246 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Berenberg Bank restated a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 273.67.

Advanced Medical Solutions Group Trading Down 0.5%

The stock has a market cap of £450.97 million, a P/E ratio of 50.00, a P/E/G ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The company has a 50-day moving average price of GBX 216.74 and a two-hundred day moving average price of GBX 210.91.

Advanced Medical Solutions Group (LON:AMS) last released its quarterly earnings results on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. On average, research analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Insider Buying and Selling at Advanced Medical Solutions Group

In other Advanced Medical Solutions Group news, insider Eddie Johnson sold 18,726 shares of the company’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of GBX 220, for a total value of £41,197.20. Also, insider A Christopher (Chris) Meredith sold 50,510 shares of the company’s stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of GBX 218, for a total transaction of £110,111.80. Corporate insiders own 4.12% of the company’s stock.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.